Cancer nanomedicine meets immunotherapy: opportunities and challenges

Cancer nanomedicines have shown promise in combination immunotherapy, thus far mostly preclinically but also already in clinical trials. Combining nanomedicines with immunotherapy aims to reinforce the cancer-immunity cycle, via potentiating key steps in the immune reaction cascade, namely antigen r...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Acta Pharmacol Sin
Main Authors: Sun, Qingxue, Bai, Xiangyang, Sofias, Alexandros Marios, van der Meel, Roy, Ruiz-Hernandez, Eduardo, Storm, Gert, Hennink, Wim E., De Geest, Bruno, Kiessling, Fabian, Yu, Hai-jun, Lammers, Twan, Shi, Yang
Format: Artigo
Jezik:Inglês
Izdano: Springer Singapore 2020
Teme:
Review Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7470866/
https://ncbi.nlm.nih.gov/pubmed/32555445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41401-020-0448-9
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki